Back to School: How biopharma can reboot drug development. Access exclusive analysis here

INCB18424: Phase Ib/IIa data

In a placebo-controlled, dose-escalation Phase Ib/IIa trial

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE